GPX4 and cervical cancer: These results suggested that MTCH1-deficiency reduced mitochondrial NAD+ levels and inhibited FoxO1 activation, which subsequently downregulated GPX4 transcription and accumulated ROS, ultimately triggering ferroptosis in cervical cancer cells.